SLNO
|
US |
SOLENO THERAPEUTICS INC |
494,424 |
$22M |
7.94% |
80.2%
|
- |
MRUS
|
US |
MERUS NV |
463,840 |
$20M |
6.97% |
478.6%
|
- |
ITCI
|
US |
INTRA-CELLULAR THERAPIES INC |
219,719 |
$18M |
6.56% |
1.5%
|
- |
ACLX
|
US |
ARCELLX INC |
229,785 |
$18M |
6.30% |
100.0%
|
- |
NVO
|
US |
NOVO-NORDISK A/S-SPONS ADR |
200,000 |
$17M |
6.15% |
-73.0%
|
- |
NVO
|
US |
NOVO-NORDISK A/S-SPONS ADR |
200,000 |
$17M |
6.15% |
-73.0%
|
Put |
NUVL
|
US |
NUVALENT INC-A |
204,045 |
$16M |
5.71% |
1221.8%
|
- |
PCVX
|
US |
VAXCYTE INC |
162,255 |
$13M |
4.75% |
112.8%
|
- |
ALNY
|
US |
ALNYLAM PHARMACEUTICALS INC |
56,400 |
$13M |
4.74% |
61.1%
|
- |
AZN
|
US |
ASTRAZENECA PLC-SPONS ADR |
190,752 |
$12M |
4.47% |
-
|
- |
RVMD
|
US |
REVOLUTION MEDICINES INC |
284,190 |
$12M |
4.44% |
196.4%
|
- |
VRNA
|
US |
VERONA PHARMA PLC - ADR |
255,318 |
$12M |
4.24% |
71.8%
|
- |
INSM
|
US |
INSMED INC |
167,939 |
$12M |
4.14% |
217.2%
|
- |
PTGX
|
US |
PROTAGONIST THERAPEUTICS INC |
293,851 |
$11M |
4.05% |
136.1%
|
- |
XBI
|
US |
SPDR S&P BIOTECH ETF |
100,000 |
$9M |
3.22% |
100.0%
|
Put |
JANX
|
US |
JANUX THERAPEUTICS INC |
162,976 |
$9M |
3.12% |
100.0%
|
- |
ARGX
|
US |
ARGENX SE - ADR |
11,311 |
$7M |
2.49% |
-25.3%
|
- |
NBIX
|
US |
NEUROCRINE BIOSCIENCES INC |
45,000 |
$6M |
2.20% |
-
|
- |
NVO
|
US |
NOVO-NORDISK A/S-SPONS ADR |
50,000 |
$4M |
1.54% |
-73.0%
|
Call |
VKTX
|
US |
VIKING THERAPEUTICS INC |
90,279 |
$4M |
1.30% |
-83.1%
|
- |